Statistics for Fulgent Genetics (id:6486 FLGT)

Valuation metrics

Market cap

528.54M

Enterprise value

313.30M

Trailing P/E (ttm)

-3.07

Forward P/E

-33.88

PEG ratio

-33.88

Price/Sales (ttm)

1.90

Price/Book (mrq)

0.46

Enterprise Value/Revenue

1.13

Enterprise Value/EBITDA

-5.15

Overview

Shares outstanding

30.59M

Float

20.42M

Shares short

645.62K

% Held by insiders

0.32%

% Held by institutions

0.54%

Average volume (10 days)

313.56K

Average volume (90 days)

Price summary

52-Week low

16.56

52-Week high

30.68

52-Week change

-59.03%

Beta

1.51

50-Day moving average

20.59

200-Day moving average

21.72

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-59.39%

Operating margin

-23.81%

Operational effectiveness

Return on assets

-4.15%

Return on equity

-14.35%

Income statement

Revenue (ttm)

9.26

Revenue per share (ttm)

9.26

Quarterly revenue growth (yoy)

Gross profit (ttm)

104.46M

EBITDA

71.08M

Net income to common (ttm)

-164,968,992.00

Diluted EPS (ttm)

-5.52

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

213.07M

Total cash per share (mrq)

6.97

Total debt (mrq)

9.94M

Total Debt/Equity (mrq)

0.88

Current ratio (mrq)

441.30%

Book value per share (mrq)

37.28

Cash flow

Cash flow statement

10.98M

Levered free cash flow (LFCF)

-35,431,752.00